Richmond, CA6 Active Studies

Leukemia Clinical Trials in Richmond, CA

Find 6 actively recruiting leukemia clinical trials in Richmond, CA. Connect with local research sites and explore new treatment options.

6
Active Trials
4
Sponsors
402
Enrolling

Recruiting Leukemia Studies in Richmond

NCT06137118Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

This is a Phase 1/2, global multicentre, open-label, single-arm, dose escalation and dose optimisation study of AZD0486 to evaluate the safety, tolerability, and efficacy of AZD0486 monotherapy in par...

Richmond, CA236 participantsAstraZeneca
View Study Details
NCT06794229Recruiting

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

All subjects will receive zanzalintinib 100mg orally (PO) once daily plus nivolumab standard of care dosing (i.e., 240mg IV every 2 weeks or 480mg IV every 4 weeks) for a total of 12 weeks, followed b...

Richmond, CA69 participantsQian Qin
View Study Details
NCT06731413Recruiting

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Evaluate frequency of adverse events that lead to chemotherapy discontinuation in vulnerable older adults with recurrent/metastatic PD-L1 TPS\<50% NSCLC patients who receive reduced dose chemotherapy ...

Richmond, CA40 participantsVirginia Commonwealth University
View Study Details
NCT06248606Recruiting

Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

This is a single arm phase 2 trial is to evaluate the efficacy of SRS plus adagrasib for the treatment of brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC). A tot...

Richmond, CA30 participantsRyan Gentzler, MD
View Study Details
NCT07130695Recruiting

Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

Treatment with olutasidenib for isocitrate dehydrogenase 1 (IDH1) mutant acute myeloid leukemia (AML) after completion of traditional intensive induction/consolidation is likely to be safe, tolerable,...

Richmond, CA15 participantsVirginia Commonwealth University
View Study Details
NCT06370000Recruiting

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Test feasibility of an oral maintenance strategy for transplant eligible AML patients in first CR who are medically underserved or have a disadvantage in the CDC SDOH domains...

Richmond, CA12 participantsVirginia Commonwealth University
View Study Details

About Leukemia Clinical Trials in Richmond

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 6 leukemia clinical trials recruiting participants in Richmond, CA. These studies are seeking a combined 402 participants. Research is being sponsored by AstraZeneca, Qian Qin, Virginia Commonwealth University and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Richmond — FAQ

Are there leukemia clinical trials in Richmond?

Yes, there are 6 leukemia clinical trials currently recruiting in Richmond, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Richmond?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you about next steps.

Are clinical trials in Richmond free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 6 active trials in Richmond are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov